Turinabol (4-Chlorodehydromethyltestosterone)
Active Substance: Turinabol
Description
Turinabol (4-Chlorodehydromethyltestosterone) is an anabolic-androgenic steroid (AAS).
1. Detailed Explanation and Other Names
-
Chemical Name: 4-Chlorodehydromethyltestosterone (CDMT)
-
Brand/Other Names: Oral-Turinabol, T-bol, Dehydrochloromethyltestosterone, 4-Chloromethandienone.
-
Description: Turinabol is an oral anabolic steroid derived from Metandienone (Dianabol) but with a modification: the addition of a chlorine atom at the 4-position of the steroid structure.
-
Key Characteristic: This modification prevents the steroid from being converted (aromatized) into estrogen. It was originally developed in East Germany and patented in 1961, known for promoting muscle growth and athletic performance with a reportedly lower incidence of androgenic side effects compared to many other steroids.
2. Benefits, Side Effects, and Pros & Cons
3. Dosage, Frequency, Half-Life, and Detection Time
4. Estrogenic, Progestogenic, and Prolactin Effects
5. Anabolic to Androgenic Ratio (A:A Ratio)
The widely cited Anabolic to Androgenic ratio for Turinabol (4-Chlorodehydromethyltestosterone) is:
(For comparison, Testosterone is generally considered to have a ratio of
).Pharmacological Properties
Half Life
15.8 hours
Active Dose
100%
Detection
3.30 days
Concentration
10 mg/tab
Anabolic/Androgenic Profile
Usage Effectiveness
Activity Profile
Estrogenic
None
Progestanic
None
Water Retention
None
Aromatization
No
Benefits
Dosage Recommendations
Beginner
20-40 mg/week
Intermediate
40-60 mg/week
Advanced
60-100 mg/week
Evidence-based planning resources
Dive deeper into Turinabol (4-Chlorodehydromethyltestosterone) cycle design, stacking options, and harm-reduction checklists available inside Anabolic Planner.
- Turinabol (4-Chlorodehydromethyltestosterone) compound database overviewCompare Turinabol (4-Chlorodehydromethyltestosterone) with other steroid agents in the structured compound index.
- Turinabol (4-Chlorodehydromethyltestosterone) stack and cycle templatesReview evidence-based cycle outlines, dose progressions, and PCT pairings that incorporate Turinabol (4-Chlorodehydromethyltestosterone).
- Harm-reduction guide for Turinabol (4-Chlorodehydromethyltestosterone)Refresh safety monitoring, lab work, and countermeasure strategies tailored for Turinabol (4-Chlorodehydromethyltestosterone) protocols.
Peer-reviewed reference material
Validate mechanisms, contraindications, and regulatory guidance for Turinabol (4-Chlorodehydromethyltestosterone) with trusted clinical databases.
- Turinabol clinical research on PubMedSearch peer-reviewed human and veterinary studies discussing efficacy, endocrine impact, and contraindications.
- Turinabol pharmacology via Drug Information PortalReview mechanisms, synonyms, regulatory status, and toxicology summaries from the U.S. National Library of Medicine.
Side Effects
Common
Severe
Safety Information
Liver Toxicity
High
Kidney Toxicity
Low
Cardiovascular Risk
Moderate
Disclaimer: This information is for educational purposes only. Always consult with a qualified healthcare professional before using any compounds.